Helene Haegel
Company: Roche
Job title: Principal Scientist Immunosafety
Seminars:
Have The Speakers Answer Your Questions 10:45 am
day: Day Two
Immunogenicity Risk Assessment For AAV-Based Gene Therapies 9:45 am
Which criteria should be taken into account for the immunogenicity risk assessment of AAV-based gene therapies? Which assay systems are available or in development to evaluate those risks?Read more
day: Day Two